CONTACT INFORMATION
Specialties
Brain Tumors, Cancers of the Blood and Blood Cells, Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Refractory Lymphoma, Relapsed Lymphoma, Amyloidosis
Board Certifications
Internal Medicine - General Cert: AM Board of Internal Medicine
Publications
Management of diffuse low-grade cerebral gliomas. Prabhu,V.; Khaldi,A.; Barton,K.; Melian,E.; Schneck,M. J.; Primeau,M.; Lee,J. M. Neurology Clinics 2010 ;28(4):1037-1059
Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e., Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literature Higa,B.; Alkan,S.; Barton,K.; Velankar,M. Pathology 2009 ;41(5):495-498
Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation. Levey,S. A.; Bajwa,R. S.; Picken,M. M.; Clark,J. I.; Barton,K.; Leehey,D. J. NDT Plus 2008 ;3( ):154-156
Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. Levitt,M. R.; Benedict,W. J.; Barton,K.; Melian,E.; Gamelli,R. L.; Vandevender,D.; Rosseau,G.; Prabhu,V. C. Journal of Burn Care & Research 2007 ;28(3):524-529
Recurrent strokes in two patients with POEMS syndrome and Castleman's disease. Garcia,T.; Dafer,R. M.; Hocker,S.; Schneck,M.; Barton,K.; Biller,J. Journal of Stroke & Cerebrovascular Diseases 2007 ;16(6):278-284
Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Kapur,U.; Barton,K.; Fresco,R.; Leehey,D. J.; Picken,M. M. Archives of Pathology & Laboratory Medicine 2007 ;131(9):1368-1372
Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Nand,S.; Barton,K. Leukemia & lymphoma 2007 ;48(2):215-216
A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem,M.; Harrison,K.; Barton,K.; Nand,S.; Alkan,S. European journal of haematology 2006 ;76(2):164-166
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Houde,C.; Li,Y.; Song,L.; Barton,K.; Zhang,Q.; Godwin,J.; Nand,S.; Toor,A.; Alkan,S.; Smadja,N. V.; Avet-Loiseau,H.; Lima,C. S.; Miele,L.; Coignet,L. J. Blood 2004 ;104(12):3697-3704
Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. Khan,S. B.; Maududi,T.; Barton,K.; Ayers,J.; Alkan,S. British journal of haematology 2004 ;125(2):156-161
Education
Medical School
The Ohio State University College of Medicine and Public Health
Residency
University of Chicago Hospitals and Clinics, Internal Medicine: General
Fellowship
University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology